Cytek Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe - Seite 2

Also at the show, Cytek scientists will conduct two tutorial sessions. Cytek’s global scientific director, Diana L. Bonilla Escobar, Ph.D., will lead a session titled, “The Balancing Act Between Number of Colors and Data Quality: Lessons Learned from Human Memory T Cells,” on Monday, May 6, from 12:15 p.m. – 1:15 p.m. Additionally, Maria C. Jaimes, M.D., vice president of scientific commercialization for Cytek, will conduct a session titled, “Are All Spectral Cytometers Equal? An Analysis from The Perspective of Multicolor Assay Performance,” on Tuesday, May 7, from 12:15 p.m. – 1:15 p.m.

"At Cytek, we’re focused on delivering innovative, powerful solutions that enable scientists to rapidly and efficiently obtain deep insights and understanding of biological systems,” said Wenbin Jiang, Ph.D., CEO of Cytek Biosciences. “Our continued participation in the scientific community’s most important events underscores our commitment to providing researchers with the tools they need to drive groundbreaking discoveries."

For more information, please visit www.cytekbio.com.

About Cytek Biosciences, Inc.
Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling (FSP) technology. Cytek’s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek’s FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the flow cytometer and imaging products under the Amnis and Guava brands; the Cytek Orion reagent cocktail preparation system, and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at www.cytekbio.com.

Cytek’s products are for research use only and not for use in diagnostic procedures (other than Cytek’s Northern Lights-CLC system and certain reagents, which are available for clinical use in China and the European Union).

Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Cytek Orion, Amnis and Guava are trademarks of Cytek Biosciences, Inc.

In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X (formerly Twitter) account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek’s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.